Without a cancer cell-targeted drug delivery system (DDS), HSP90 inhibitors could be harmful and toxic to normal cells, leading to unfavorable side effects (potential usefulness of nano-vesicles such as DDS is mentioned below). The gene discussed is HSP90AA1; the disease is cancer.